0B68 Austin, Matthew S. - Thomas Jefferson University - Thomas Jefferson University
msa101

Matthew S. Austin, BS, MD

Contact Dr. Austin

925 Chestnut Street
5th Floor
Philadelphia, PA 19107

(267) 339-3500
(800) 321-9999 fax

Most Recent Peer-reviewed Publications

  1. What Is the Level of Evidence Substantiating the Medicare Local Coverage Determinations?
  2. Medicare fails to compensate additional surgical time and effort associated with revision arthroplasty
  3. Bacterial Contamination in Tips of Electrocautery Devices During Total Hip Arthroplasty
  4. Revision total knee arthroplasty in the young patient: Is there trouble on the horizon?
  5. Operative Environment
  6. Revision total knee arthroplasty using metaphyseal sleeves at short-term follow-up
  7. Differing effects of denosumab and alendronate on cortical and trabecular bone
  8. Pulmonary embolism after total joint arthroplasty: Cost and effectiveness of four treatment modalities
  9. A systematic review of open reduction and internal fixation of periprosthetic femur fractures with or without allograft strut, cerclage, and locked plates
  10. Revision knee arthroplasty for bone loss: Choosing the right degree of constraint
  11. Head computed tomography is not useful for evaluating patients change in mental status following total joint arthroplasty
  12. Operative environment
  13. Negative pressure wound therapy is associated with resolution of incisional drainage in most wounds after hip arthroplasty
  14. Swab cultures are not as effective as tissue cultures for diagnosis of periprosthetic joint infection
  15. The effect of malnutrition on patients undergoing elective joint arthroplasty
  16. Revision total hip arthroplasty in younger patients: Indications, reasons for failure, and survivorship
  17. Intra-articular infusion with bupivacaine decreased pain and opioid consumption after total knee arthroplasty
  18. Obesity and total joint arthroplasty. A literature based review
  19. Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial
  20. Reply to letter to the editor: Operating room traffic is a major concern during total joint arthroplasty
0